Kezar Life Sciences, Inc. (KZR) Social Stream



Kezar Life Sciences, Inc. (KZR): $2.78

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

B

Stability

D

Sentiment

Quality

C

Add KZR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#345 of 378

in industry

KEZAR LIFE SCIENCES INC (KZR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KZR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 4 $15 $12 $13.5 $2.86 372.03%
2021-11-16 4 $20 $15 $17.5 $2.86 511.89%
2021-12-08 5 $20 $15 $18 $2.86 529.37%
2022-03-18 5 $27 $19 $22.666 $2.86 692.52%
2022-05-04 5 $22 $14 $19 $2.86 564.34%
2022-06-28 5 $22 $14 $18.666 $2.86 552.66%
2023-01-03 5 $21 $14 $17.333 $2.86 506.05%
2023-03-16 5 $21 $14 $16.666 $2.86 482.73%
2023-05-11 5 $21 $14 $16.666 $2.86 482.73%
2023-05-12 5 $19 $13 $15.666 $2.86 447.76%

The Trend in the Analyst Price Target


KZR's average price target has moved up $2.5 over the prior 19 months.

KZR reports an average of 260.99% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-12 5 21 14 17.333 10.35 67.47%
2022-10-04 5 21 14 17.333 8.51 103.68%
2023-05-11 5 21 14 16.666 2.60 541%
2023-05-12 5 19 14 16.000 2.62 510.69%
2023-05-12 5 19 13 15.666 2.62 497.94%

KZR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 48 weeks, KZR's average broker recommendation rating worsened by 0.4.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, KEZAR LIFE SCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 1118.18% of them.
  • In the context of all US stocks, KEZAR LIFE SCIENCES INC's number of analysts covering the stock is greater than 251.94% of them.
  • In the context of Pharmaceutical Products stocks, KEZAR LIFE SCIENCES INC's variance in analysts' estimates is lower than -152.81% of them.
  • In the context of Healthcare stocks, KEZAR LIFE SCIENCES INC's average analyst price target is greater than 383.08% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KEZAR LIFE SCIENCES INC are XERS, VRCA, and ITRM.

What is the outlook for KZR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9369 seconds.